Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures
暂无分享,去创建一个
S. Cummings | J. Cauley | M. Nevitt | D. Bauer | H. Genant | R. Marcus | W. Haskell | K. Ensrud | J. Torner | D. Black | S. Ott | S. Quandt | D. Karpf | T. Reiss | D. Thompson
[1] R. Recker,et al. Effect of Oral Alendronate on Bone Mineral Density and the Incidence of Fractures in Postmenopausal Osteoporosis , 1996 .
[2] B. Adams-Huet,et al. Treatment of Postmenopausal Osteoporosis with Slow-Release Sodium Fluoride: Final Report of a Randomized Controlled Trial , 1995, Annals of Internal Medicine.
[3] Robert Epstein,et al. Comparison of methods for defining prevalent vertebral deformities: The study of osteoporotic fractures , 1995, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[4] S. Greenspan,et al. Femoral bone loss progresses with age: A longitudinal study in women over age 65 , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[5] C. Cooper,et al. Risk of hip fracture in women with vertebral fracture , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] H. Genant,et al. Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: three years of blinded therapy followed by one year of open therapy. , 1993, The American journal of medicine.
[7] M. Nevitt,et al. Vertebral fracture assessment using a semiquantitative technique , 1993, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[8] H. Kang,et al. Vertebral Fracture in Osteoporosis , 1993 .
[9] Caroline S. Fox,et al. Hormone Therapy To Prevent Disease and Prolong Life in Postmenopausal Women , 1992, Annals of Internal Medicine.
[10] F Duboeuf,et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. , 1992, The New England journal of medicine.
[11] M. A. Hansen,et al. Effect of salcatonin given intranasally on bone mass and fracture rates in established osteoporosis: a dose-response study. , 1992, BMJ.
[12] L. Melton,et al. The prevention and treatment of osteoporosis. , 1992, The New England journal of medicine.
[13] A. Lane,et al. Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen , 1992, Annals of Internal Medicine.
[14] G. Spears,et al. Treatment of postmenopausal osteoporosis with calcitriol or calcium. , 1992, The New England journal of medicine.
[15] S. Cummings,et al. Which Fractures Are Associated with Low Appendicular Bone Mass in Elderly Women , 1991 .
[16] R. Epstein,et al. Pre-existing fractures and bone mass predict vertebral fracture incidence in women. , 1991, Annals of internal medicine.
[17] W. O'Fallon,et al. Risk of hip fracture among women with vertebral fractures , 1990 .
[18] W. Mysiw,et al. Intermittent cyclical etidronate treatment of postmenopausal osteoporosis. , 1990, The New England journal of medicine.
[19] H. Genant,et al. Effect of intermittent cyclical etidronate therapy on bone mass and fracture rate in women with postmenopausal osteoporosis. , 1990, The New England journal of medicine.
[20] S. Cummings,et al. Lifetime risks of hip, Colles', or vertebral fracture and coronary heart disease among white postmenopausal women. , 1989, Archives of internal medicine.
[21] S. H. Kan,et al. Epidemiology of vertebral fractures in women. , 1989, American journal of epidemiology.
[22] D. Kiel,et al. Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study. , 1987, The New England journal of medicine.
[23] G Block,et al. Evaluation of two food frequency methods of measuring dietary calcium intake. , 1987, American journal of epidemiology.
[24] R. Lindsay,et al. Long term effect of oestrogen replacement therapy on bone mass as measured by dual photon absorptiometry. , 1987, British medical journal.
[25] D. Cox,et al. Analysis of Survival Data. , 1985 .
[26] W. O'Fallon,et al. Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. , 1982, The New England journal of medicine.